COMMUNIQUÉS West-GlobeNewswire

GN Store Nord A/S utilises attractive market conditions and launches refinancing of convertible bond, consisting of Bond with Warrant Units
14/05/2019
NOT FOR DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ITALY, OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. [...]
Aino Health AB (publ): Aino Health interim report January-March 2019
14/05/2019
14 May 2019 Aino Health interim report January-March 2019 - Large deal with client in Finland, improved profit, net sales, and cash flow, the business model is showing results. January-March 2019 · Net sales increased [...]
GENFIT: Positive 36-month DSMB Recommendation for Continuation of Phase 3 RESOLVE-IT Study of Elafibranor in NASH
14/05/2019
GENFIT: Positive 36-month DSMB Recommendation for Continuation of Phase 3 RESOLVE-IT Study of Elafibranor in NASH Data Safety Monitoring Board (DSMB) recommends the continuation of the RESOLVE-IT clinical trial without [...]
GENFIT : Issue positive du DSMB à 36 mois, recommandant la poursuite de l’étude clinique de Phase 3 RESOLVE-IT évaluant elafibranor dans la NASH
14/05/2019
GENFIT : Issue positive du DSMB à 36 mois, recommandant la poursuite de l’étude clinique de Phase 3 RESOLVE-IT évaluant elafibranor dans la NASH Le Data Safety Monitoring Board (DSMB) a recommandé la poursuite de l’ [...]
DBV Technologies Announces Departure of Deputy CEO David Schilansky
14/05/2019
Montrouge, France, May 14, 2019 DBV Technologies Announces Departure of Deputy CEO David Schilansky DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical [...]
DBV Technologies Annonce le Départ de son Directeur Général Délégué, David Schilansky
14/05/2019
Montrouge, France, le 14 Mai (07h30 CET), 2019 DBV Technologies Annonce le Départ de son Directeur Général Délégué, David Schilansky DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Bourse Nasdaq : DBVT), [...]
Fagron NV: Fagron shareholders approve all proposed resolutions
14/05/2019
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), May 14 th , 2019 - 7:00am CET Fagron shareholders approve all proposed resolutions Fagron announces today that the annual general meeting of [...]
TOMI Environmental Solutions, Inc. to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 20, 2019
14/05/2019
BEVERLY HILLS, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX:TOMZ), a global company specializing in disinfection and decontamination essentials announced it will hold its [...]
Applied Therapeutics Announces Pricing of Initial Public Offering
14/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/05/2019
WALTHAM Mass. and CRESTWOOD, Ky., May 13, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Axcella Health Announces Closing of Initial Public Offering
13/05/2019
CAMBRIDGE, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and [...]
Amicus Therapeutics Appoints Burke W. Whitman to its Board of Directors
13/05/2019
CRANBURY, N.J., May 13, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the election and appointment of Burke W. Whitman to its Board of Directors, effective at the end of this quarter. Mr. [...]
DiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Update
13/05/2019
Phase Ib study of DM199 in Chronic Kidney Disease nearing full enrollment Completion of new cGMP manufacturing run of DM199 Conference call with management tomorrow, May 14, 2019 at 7am CT MINNEAPOLIS, May 13, 2019 ( [...]
T2 Biosystems Reports Granting of Inducement Awards
13/05/2019
LEXINGTON, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
STERIS Announces Financial Results for Fiscal 2019 Fourth Quarter and Full Year
13/05/2019
Strong fourth quarter revenue growth Fourth quarter earnings improve to $1.27 per diluted share as reported; adjusted earnings per diluted share increase to $1.53 Full year fiscal 2019 revenue growth and adjusted [...]
Myovant Sciences to Host Webcast and Conference Call at 8:30 a.m. Eastern Time Tuesday, May 14th to Discuss Results from Phase 3 LIBERTY 1 Study Evaluating Once Daily Relugolix Combination Therapy in Women with Uterine Fibroids
13/05/2019
BASEL, Switzerland, May 13, 2019 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE:MYOV), a clinical-stage healthcare company focused on developing and commercializing innovative therapies for women’s health and prostate [...]
LHC Group to Present at Three Healthcare Conferences in May
13/05/2019
LAFAYETTE, La., May 13, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that over the next two weeks the Company is presenting at the Bank of America Merrill Lynch 2019 Health Care Conference in [...]
Homology Medicines Reports First Quarter 2019 Financial Results and Recent Highlights
13/05/2019
- Received FDA Clearance for IND and Anticipate Starting Phase 1/2 pheNIX Trial for PKU Gene Therapy Candidate with Initial Data Expected by Year End - - Began IND-Enabling Studies for Two Additional Programs, Including [...]
Crinetics Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
13/05/2019
SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Pages